Research articlePublished 20 Jun 2019
K16ApoE Enhances A β-associated 11C-PiB Deposition and PET Signal in APP/ PS1 Transgenic Mice
1Departments of Neurosurgery, Mayo Clinic, Rochester, MN, USA; 2Departments of Experimental Pathology, Mayo Clinic, Rochester, MN, USA; 3Departments of Nuclear Medicine, Mayo Clinic, Rochester, MN, USA; 4Departments of Neurology, Mayo Clinic, Rochester, MN, USA; 5Department of Pharmaceutics and Brain Barriers Research Center, University of Minnesota, Minneapolis, MN, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Objective: Transgenic mouse models are central to the study of Alzheimer’s disease and aid in elucidating the underlying pathophysiology. Mouse models also provide a system in which to test potential therapeutic strategies. PET imaging plays a central clinical role in diagnosing human cases of Alzheimer’s disease but has had variable performance in mouse models. We investigated the potential role of the K16ApoE carrier peptide to enhance delivery of a radiolabeled PET imaging tracer, 11C-PiB and assess whether this corresponds to improved sensitivity of the PET modality in APP/PS1 transgenic mice. Methods: Brain-delivery of 11C-PiB was accomplished by sequential bolus injections of K16ApoE and 11C-PiB via femoral vein injections. Distribution of 11C-PiB to the brain and heart was quantified via dynamic PET/CT imaging and digital autoradiography. Results: K16ApoE carrier peptide increased the brain uptake of 11C-PiB in both wild-type and APP/PS1 mice. Administration of K16ApoE increased the PET standard uptake value of 11C-PiB at 5 minutes in WT mice from 1.132 to 2.963 (p=0.006) and in APP/PS1 mice from 0.842 to 3.268 (p=0.016). Enhancement peaked at 5 minutes. Binding was reversible as demonstrable by Logan plots with similarly increased kinetics in both WT and APP/PS1 mice. The absolute values were higher in APP/PS1 mice suggesting increased retention. The increased retention in APP/PS1 mice was consistent with specific binding to Aβ plaques as unlabeled PiB showed competitive reduction of 11C-PiB signal retention. Conclusion: K16ApoE-mediates enhancement of 11C-PiB signal in APP/PS1 mice brains with increase in the PET sensitivity. There is increased uptake kinetics in both WT and APP/PS1 mice with specific retention due to Aβ plaque binding in the latter. This improved sensitivity of PET scanning in the APP/PS1 transgenic mouse model. Such enhanced delivery of this PET tracer has implications for development and testing of new hypotheses and the efficacy of novel therapeutic paradigms.
Keywords
Subjects
Neuroscience & NeurologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Alzheimers Disease & Parkinsonism
- SubjectNeuroscience & Neurology
- BylineArticles whose byline prints “Brown DA”
- BylineArticles whose byline prints “Sarkar G”
- BylineArticles whose byline prints “Decklever TD”
- BylineArticles whose byline prints “Curran GL”
- BylineArticles whose byline prints “Sarkar AJ”
- BylineArticles whose byline prints “Schmeichel AM”
- BylineArticles whose byline prints “Swaminathan SK”
- BylineArticles whose byline prints “Kandimala KK”